Massimo Loda

80.2k total citations · 14 hit papers
469 papers, 40.1k citations indexed

About

Massimo Loda is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Massimo Loda has authored 469 papers receiving a total of 40.1k indexed citations (citations by other indexed papers that have themselves been cited), including 239 papers in Molecular Biology, 182 papers in Pulmonary and Respiratory Medicine and 160 papers in Cancer Research. Recurrent topics in Massimo Loda's work include Prostate Cancer Treatment and Research (145 papers), Cancer, Lipids, and Metabolism (99 papers) and Cancer-related Molecular Pathways (53 papers). Massimo Loda is often cited by papers focused on Prostate Cancer Treatment and Research (145 papers), Cancer, Lipids, and Metabolism (99 papers) and Cancer-related Molecular Pathways (53 papers). Massimo Loda collaborates with scholars based in United States, Italy and United Kingdom. Massimo Loda's co-authors include Sabina Signoretti, William R. Sellers, Todd R. Golub, Shuji Ogino, Charles S. Fuchs, Christine Ladd, Eric S. Lander, Phillip G. Febbo, Michele Pagano and Giorgia Zadra and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Massimo Loda

458 papers receiving 39.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

2001 2.0k citations Massimo Loda, Todd R. Golub et al. Proceedings of the National Academy of Sciences profile →
Gene expression correlates of clinical prostate cancer behavior

2002 1.8k citations Phillip G. Febbo, Massimo Loda et al. profile →
Multiclass cancer diagnosis using tumor gene expression signatures

2001 1.5k citations Massimo Loda, Todd R. Golub et al. Proceedings of the National Academy of Sciences profile →
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.

1997 1.2k citations Massimo Loda et al. profile →
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

1997 910 citations Massimo Loda et al. profile →
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

2004 781 citations Pradip K. Majumder, Phillip G. Febbo et al. profile →
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

2000 685 citations Massimo Loda et al. profile →
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

2017 680 citations Sheng‐Yu Ku, Spencer R. Rosario et al. Science profile →
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

2008 594 citations Massimo Loda, Edward L. Giovannucci et al. profile →
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

1998 556 citations George Thomas, Massimo Loda et al. Proceedings of the National Academy of Sciences profile →
Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis

2008 553 citations Sabina Signoretti, Massimo Loda et al. profile →
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease

2002 514 citations Massimo Loda et al. profile →
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.

1999 500 citations Massimo Loda, William R. Sellers et al. profile →
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

2020 408 citations Massimo Loda et al. profile →

Peers

Countries citing papers authored by Massimo Loda

Since Specialization

Citations

This map shows the geographic impact of Massimo Loda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Loda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Loda more than expected).

Fields of papers citing papers by Massimo Loda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Loda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Loda. The network helps show where Massimo Loda may publish in the future.

Co-authorship network of co-authors of Massimo Loda

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Loda. A scholar is included among the top collaborators of Massimo Loda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Loda. Massimo Loda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum 2020 ·Molecular Cancer Research ·Kathryn L. Penney, Svitlana Tyekucheva, Jacob Rosenthal, (unknown), (unknown), (unknown), Giorgia Zadra, Giuseppe Nicolò Fanelli, (unknown), Francesca Giunchi, Mark M. Pomerantz, (unknown), (unknown), Rosina T. Lis, Adam S. Kibel, Michelangelo Fiorentino, Renato Umeton, Massimo Loda	28
2	Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9 2020 ·Molecular Cancer Research ·Harri M. Itkonen, Ninu Poulose, Rebecca E. Steele, Sara E. Martin, Zebulon G. Levine, Damien Duveau, (unknown), Reema Singh, Alfonso Urbanucci, Massimo Loda, Craig J. Thomas, Ian G. Mills, Suzanne Walker	41
3	Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning 2020 ·Clinical Chemistry ·He S. Yang, Yu Hou, Ljiljana V. Vasović, Peter A.D. Steel, Amy Chadburn, Sabrina Racine‐Brzostek, Priya Velu, Melissa M. Cushing, Massimo Loda, Rainu Kaushal, Zhen Zhao, Fei Wang	76
4	Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell–Level PI3K Pathway Activation 2020 ·Clinical Cancer Research ·Konrad H. Stopsack, Ying Huang, Svitlana Tyekucheva, Travis Gerke, Clyde Bango, Habiba Elfandy, Michaela Bowden, Kathryn L. Penney, Thomas M. Roberts, Giovanni Parmigiani, Philip W. Kantoff, Lorelei A. Mucci, Massimo Loda	7
5	Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging 2019 ·Molecular Cancer Research ·Elizabeth C. Randall, Giorgia Zadra, Paolo Chetta, Begoña Giménez, Sudeepa Syamala, Sankha S. Basu, Jeffrey N. Agar, Massimo Loda, Clare M. Tempany, Fiona M. Fennessy, Nathalie Y.R. Agar	48
6	Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations 2018 ·Cancer Research ·Adam G. Sowalsky, Huihui Ye, Manoj Bhasin, Eliezer M. Van Allen, Massimo Loda, Rosina T. Lis, Laleh Montaser‐Kouhsari, Carla Calagua, Fen Ma, Joshua W. Russo, Rachel Schaefer, Olga Voznesensky, Zhenwei Zhang, Glenn J. Bubley, Bruce Montgomery, Elahe A. Mostaghel, Peter S. Nelson, Mary‐Ellen Taplin, Steven P. Balk	38
7	Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance breakdown → 2017 ·Science ·Sheng‐Yu Ku, Spencer R. Rosario, Yanqing Wang, Ping Mu, Mukund Seshadri, (unknown), (unknown), David P. Labbé, Eduardo Cortes Gomez, Jianmin Wang, Henry W. Long, Bo Xu, Myles Brown, Massimo Loda, Charles L. Sawyers, Leigh Ellis, David W. Goodrich	680
8	Metabolic Profiling in Formalin-Fixed and Paraffin-Embedded Prostate Cancer Tissues 2017 ·Molecular Cancer Research ·Stefano Cacciatore, Giorgia Zadra, Clyde Bango, Kathryn L. Penney, Svitlana Tyekucheva, Óscar Yanes, Massimo Loda	47
9	The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women 2016 ·Cancer Research ·Sung Jin Huh, Hannah Oh, Michael Peterson, Vanessa Almendro, Rong Hu, Michaela Bowden, (unknown), Maura B. Cotter, Massimo Loda, William T. Barry, Kornélia Polyák, Rulla M. Tamimi	41
10	Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers 2016 ·Cancer Discovery ·Sarah Naomi Olsen, Ania Wronski, Zafira Castaño, Benjamin T. Dake, Clare F. Malone, Thomas De Raedt, Miriam Enos, Yoko S. DeRose, Wenhui Zhou, Stephanie Guerra, Massimo Loda, Alana L. Welm, Ann H. Partridge, Sandra S. McAllister, Charlotte Kuperwasser, Karen Cichowski	52
11	Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Kathryn L. Penney, Andreas Pettersson, Irene M. Shui, Rebecca E. Graff, Peter Kraft, Rosina T. Lis, Howard D. Sesso, Massimo Loda, Lorelei A. Mucci	18
12	Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer 2015 ·Clinical Cancer Research ·Donghao Lu, Jennifer A. Sinnott, Unnur Valdimarsdóttir, Fang Fang, Travis Gerke, Svitlana Tyekucheva, Michelangelo Fiorentino, Mats Lambe, Howard D. Sesso, Christopher J. Sweeney, Kathryn M. Wilson, Edward L. Giovannucci, Massimo Loda, Lorelei A. Mucci, Katja Fall	27
13	Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Kathryn L. Penney, Jennifer A. Sinnott, Svitlana Tyekucheva, Travis Gerke, Irene M. Shui, Peter Kraft, Howard D. Sesso, Matthew L. Freedman, Massimo Loda, Lorelei A. Mucci, Meir J. Stampfer	85
14	Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors 2014 ·Clinical Cancer Research ·(unknown), Adam G. Sowalsky, Shuai Gao, Changmeng Cai, Olga Voznesensky, Rachel Schaefer, Massimo Loda, Lawrence D. True, Huihui Ye, Patricia Troncoso, (unknown), Philip W. Kantoff, Bruce Montgomery, Peter S. Nelson, Glenn J. Bubley, Steven P. Balk, Mary-Ellen Taplin	139
15	Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee 2013 ·Cancer Research ·Michael Ittmann, Jiaoti Huang, Enrico Radaelli, Philip Martin, Sabina Signoretti, Ruth Sullivan, Brian W. Simons, Jerrold M. Ward, Brian D. Robinson, Gerald C. Chu, Massimo Loda, George Thomas, Alexander D. Borowsky, Robert D. Cardiff	184
16	MYC Is Activated by USP2a-Mediated Modulation of MicroRNAs in Prostate Cancer 2012 ·Cancer Discovery ·Barbara Benassi, Richard Flavin, Luigi Marchionni, Sı́lvio M. Zanata, Yunfeng Pan, Dipanjan Chowdhury, Marina Marani, Sabrina Strano, Paola Muti, Giovanni Blandino, Massimo Loda	80
17	Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer 2011 ·Cancer Epidemiology Biomarkers & Prevention ·Preet K. Dhillon, Kathryn L. Penney, Fredrick R. Schumacher, Jennifer R. Rider, Howard D. Sesso, Michaël Pollak, Michelangelo Fiorentino, Stephen P. Finn, Massimo Loda, Nader Rifai, Lorelei A. Mucci, Edward L. Giovannucci, Meir J. Stampfer, Jing Ma	48
18	Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer 2006 ·Clinical Cancer Research ·Phillip G. Febbo, Aaron R. Thorner, Mark A. Rubin, Massimo Loda, Philip W. Kantoff, William Oh, Todd R. Golub, Daniel J. George	20
19	The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells 2005 ·Proceedings of the National Academy of Sciences ·Jean J. Zhao, Zhenning Liu, Lı Wang, Eyoung Shin, Massimo Loda, Thomas M. Roberts	267
20	p63 regulates commitment to the prostate cell lineage 2005 ·Proceedings of the National Academy of Sciences ·Sabina Signoretti, Maira M. Pires, (unknown), James W. Horner, Chiara Grisanzio, (unknown), Pradip K. Majumder, Frank McKeon, Philip W. Kantoff, William R. Sellers, Massimo Loda	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact